How do you compound your topical JAK inhibitors like tofacitinib or ruxolitinib?
Featuring Seemal Desai, MD | Education Advisor | Clinical Assistant Professor Department of DermatologyUniversity of Texas Southwestern Medical CenterDallas, TX | Published September 29, 2021
Related Media
Powered by Polaris TM